8-K: Gaxos.ai Inc. Announces $4 Million Registered Direct Offering Priced At-the-Market
Capital Raise Announcement
Gaxos.ai Inc. has entered into agreements for a $4 million registered direct offering of common stock and warrants.
Summary
- Gaxos.ai Inc. has agreed to sell 1,346,669 shares of common stock at $3.00 per share in a registered direct offering.
- Concurrently, the company will issue unregistered warrants to purchase an equal number of shares at an exercise price of $3.00 per share, exercisable immediately for three years.
- The offering is expected to close on December 30, 2024, pending customary closing conditions.
- The company anticipates net proceeds of approximately $3.6 million after deducting fees and expenses.
- The funds are intended for general corporate purposes, including working capital and capital expenditures.
- H.C. Wainwright & Co. is the exclusive placement agent for the offering.
Sentiment
Score: 6
Explanation: The document is neutral to slightly positive. It details a standard capital raise, which is necessary for growth but also dilutes existing shareholders. The company's stated use of proceeds is positive, but the offering itself is not a major catalyst.
Positives
- The company is raising capital for general corporate purposes, which may include working capital and capital expenditures.
- The warrants are exercisable immediately, providing potential for future capital if exercised.
- The offering is priced at-the-market under Nasdaq rules.
Negatives
- The offering includes unregistered warrants, which may have resale restrictions.
- The company is issuing a significant number of new shares, which could dilute existing shareholders.
- The net proceeds are reduced by placement agent fees and offering expenses.
Risks
- The closing of the offering is subject to customary closing conditions, which may not be met.
- The company's use of proceeds is subject to change.
- The market price of the company's stock could be negatively impacted by the offering.
- The warrants may not be exercised, limiting the potential for future capital.
Future Outlook
The company intends to use the net proceeds from the offerings for general corporate purposes, which may include working capital and capital expenditures.
Management Comments
- Gaxos.ai isn't just developing applications; its aim is to redefine the human-AI relationship.
- Our offerings are being expanded to include health and wellness, as well as gaming.
- We're committed to addressing health, longevity, and entertainment, through AI solutions.
Industry Context
This capital raise is likely intended to fund the company's ongoing development of AI applications in various sectors, including health, wellness, and gaming, which are areas of growing interest and investment in the technology industry.
Comparison to Industry Standards
- The use of a registered direct offering is a common method for publicly traded companies to raise capital.
- The inclusion of warrants is a typical incentive for investors in such offerings.
- The placement agent fees and expenses are within the typical range for similar transactions.
- The stated use of proceeds for working capital and general corporate purposes is standard for companies in the growth phase.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Decrease in authorized shares | The stockholders approved an amendment to the Companys Amended and Restated Certificate of Incorporate to decrease the number of authorized shares of common stock of the Company from 50,000,000 to 25,000,000. | 2024-12-27 | This reduces the number of shares available for future issuance. |
| Reincorporation | The Companys stockholders approved the reincorporation of the Company from The State of Delaware to the State of Nevada. | 2024-12-27 | This changes the state of incorporation, which may have legal and tax implications. |
Stakeholder Impact
- Shareholders will experience dilution due to the issuance of new shares.
- The company will have additional capital to fund operations and growth.
- The offering may impact the company's stock price.
Next Steps
- The closing of the offering is expected on or about December 30, 2024.
- The company will file a prospectus supplement with the SEC.
- The company will use the net proceeds for working capital and general corporate purposes.
- The company will file a registration statement for the resale of the warrant shares.
Key Dates
| Date | Description |
|---|---|
| 2024-09-20 | Engagement agreement with H.C. Wainwright & Co., LLC as exclusive placement agent. |
| 2024-11-19 | Company's Definitive Proxy Statement filed with the SEC. |
| 2024-12-12 | Shelf registration statement on Form S-3 filed with the SEC. |
| 2024-12-18 | Shelf registration statement declared effective by the SEC. |
| 2024-12-26 | Date of the securities purchase agreement and earliest event reported. |
| 2024-12-27 | Company held its 2024 annual meeting of stockholders and issued a press release announcing the pricing of the Offerings. |
| 2024-12-30 | Expected closing date of the offering. |
Keywords
registered direct offering, common stock, warrants, private placement, capital raise, working capital, H.C. Wainwright, GXAI, artificial intelligence
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.